159 related articles for article (PubMed ID: 34854748)
1. One-Year Results for the ROBUST III Randomized Controlled Trial Evaluating the Optilume
Elliott SP; Coutinho K; Robertson KJ; D'Anna R; Chevli K; Carrier S; Aube-Peterkin M; Cantrill CH; Ehlert MJ; Te AE; Dann J; DeLong JM; Brandes SB; Hagedorn JC; Levin R; Schlaifer A; DeSouza E; DiMarco D; Erickson BA; Natale R; Husmann DA; Morey A; Olsson C; Virasoro R
J Urol; 2022 Apr; 207(4):866-875. PubMed ID: 34854748
[TBL] [Abstract][Full Text] [Related]
2. Optilume drug-coated balloon for anterior urethral stricture: 2-year results of the ROBUST III trial.
VanDyke ME; Morey AF; Coutinho K; Robertson KJ; D'Anna R; Chevli K; Cantrill CH; Ehlert MJ; Te AE; Dann J; DeLong JM; Virasoro R; Hagedorn JC; Levin R; DeSouza E; DiMarco D; Erickson BA; Olsson C; Elliott SP
BJUI Compass; 2024 Mar; 5(3):366-373. PubMed ID: 38481667
[TBL] [Abstract][Full Text] [Related]
3. A Drug-Coated Balloon Treatment for Urethral Stricture Disease: Three-Year Results from the ROBUST I Study.
Virasoro R; DeLong JM; Estrella RE; Pichardo M; Rodriguez Lay R; Espino G; Elliott SP
Res Rep Urol; 2022; 14():177-183. PubMed ID: 35572815
[TBL] [Abstract][Full Text] [Related]
4. How I Do It: The Optilume drug-coated balloon for urethral strictures.
Elterman DS; Coutinho K; Hagedorn JC
Can J Urol; 2020 Aug; 27(4):10322-10328. PubMed ID: 32861260
[TBL] [Abstract][Full Text] [Related]
5. Balloon dilation for the treatment of male urethral strictures: a systematic review and meta-analysis.
Li X; Xu C; Ji X; Zhu Z; Cai T; Guo Z; Lin J
BMJ Open; 2024 Feb; 14(2):e071923. PubMed ID: 38320837
[TBL] [Abstract][Full Text] [Related]
6. Economic evaluation of Optilume, a drug-coated balloon for recurrent anterior male urethral stricture.
Kelly L; Shore J; Wright J; Patrick C; Holmes H
BJUI Compass; 2023 Jul; 4(4):430-436. PubMed ID: 37334026
[TBL] [Abstract][Full Text] [Related]
7. Effect of a temporary thermo-expandable stent on urethral patency after dilation or internal urethrotomy for recurrent bulbar urethral stricture: results from a 1-year randomized trial.
Jordan GH; Wessells H; Secrest C; Squadrito JF; McAninch JW; Levine L; van der Burght M;
J Urol; 2013 Jul; 190(1):130-6. PubMed ID: 23313208
[TBL] [Abstract][Full Text] [Related]
8. A drug-coated balloon treatment for urethral stricture disease: Interim results from the ROBUST I study.
Virasoro R; DeLong JM; Mann RA; Estrella RE; Pichardo M; Lay RR; Espino G; Roth JD; Elliott SP
Can Urol Assoc J; 2020 Jun; 14(6):187-191. PubMed ID: 31977303
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Paclitaxel-Coated Balloon Angioplasty for Dysfunctional Arteriovenous Fistulas: A Multicenter Randomized Controlled Trial.
Yin Y; Shi Y; Cui T; Li H; Chen J; Zhang L; Yu Z; Li H; Yan Y; Wu K; Jin Q
Am J Kidney Dis; 2021 Jul; 78(1):19-27.e1. PubMed ID: 33418016
[TBL] [Abstract][Full Text] [Related]
10. Multi-Institutional Outcomes of Endoscopic Management of Stricture Recurrence after Bulbar Urethroplasty.
Sukumar S; Elliott SP; Myers JB; Voelzke BB; Smith TG; Carolan AMC; Maidaa M; Vanni AJ; Breyer BN; Erickson BA
J Urol; 2018 Oct; 200(4):837-842. PubMed ID: 29730205
[TBL] [Abstract][Full Text] [Related]
11. Low-Dose Paclitaxel-Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon).
Schroeder H; Werner M; Meyer DR; Reimer P; Krüger K; Jaff MR; Brodmann M;
Circulation; 2017 Jun; 135(23):2227-2236. PubMed ID: 28424223
[TBL] [Abstract][Full Text] [Related]
12. The PINNACLE Study: A Double-blind, Randomized, Sham-controlled Study Evaluating the Optilume BPH Catheter System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
Kaplan SA; Moss J; Freedman S; Coutinho K; Wu N; Efros M; Elterman D; D'Anna R; Padron O; Robertson KJ; Lawindy S; Mistry S; Shore N; Spier J; Kaminetsky J; Mazzarella B; Cahn D; Jalkut M; Te A
J Urol; 2023 Sep; 210(3):500-509. PubMed ID: 37555604
[TBL] [Abstract][Full Text] [Related]
13. Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: Twelve-Month Outcomes From the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies.
Krishnan P; Faries P; Niazi K; Jain A; Sachar R; Bachinsky WB; Cardenas J; Werner M; Brodmann M; Mustapha JA; Mena-Hurtado C; Jaff MR; Holden AH; Lyden SP
Circulation; 2017 Sep; 136(12):1102-1113. PubMed ID: 28729250
[TBL] [Abstract][Full Text] [Related]
14. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
Scheinert D; Schmidt A; Zeller T; Müller-Hülsbeck S; Sixt S; Schröder H; Weiss N; Ketelsen D; Ricke J; Steiner S; Rosenfield K
J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972
[TBL] [Abstract][Full Text] [Related]
15. A drug-coated balloon treatment for urethral stricture disease: Two-year results from the ROBUST I study.
Mann RA; Virasoro R; DeLong JM; Estrella RE; Pichardo M; Lay RR; Espino G; Roth JD; Elliott SP
Can Urol Assoc J; 2021 Feb; 15(2):20-25. PubMed ID: 32744999
[TBL] [Abstract][Full Text] [Related]
16. One-Year Results for the ROBUST III Randomized Controlled Trial Evaluating the Optilume
Fujita-Rohwerder N
J Urol; 2022 Apr; 207(4):941-942. PubMed ID: 35014865
[No Abstract] [Full Text] [Related]
17. One-Year Results for the ROBUST III Randomized Controlled Trial Evaluating the Optilume
Elliott SP
J Urol; 2022 Apr; 207(4):942. PubMed ID: 35014864
[No Abstract] [Full Text] [Related]
18. High-pressure balloon dilation for male anterior urethral stricture: single-center experience.
Yu SC; Wu HY; Wang W; Xu LW; Ding GQ; Zhang ZG; Li GH
J Zhejiang Univ Sci B; 2016 Sep; 17(9):722-7. PubMed ID: 27604864
[TBL] [Abstract][Full Text] [Related]
19. Simple urethral dilatation, endoscopic urethrotomy, and urethroplasty for urethral stricture disease in adult men.
Wong SS; Aboumarzouk OM; Narahari R; O'Riordan A; Pickard R
Cochrane Database Syst Rev; 2012 Dec; 12():CD006934. PubMed ID: 23235635
[TBL] [Abstract][Full Text] [Related]
20. One-year outcomes after treatment with a drug-coated balloon catheter system for lower urinary tract symptoms related to benign prostatic hyperplasia.
Kaplan SA; Pichardo M; Rijo E; Espino G; Lay RR; Estrella R
Prostate Cancer Prostatic Dis; 2021 Dec; 24(4):1073-1079. PubMed ID: 33833379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
